Report a typo
Not reporting a typo? Please use our Contact Form
Story:
Merck to buy hepatitis C treatment maker Idenix Pharma for $3.85 billion in cash
Castanet.net does not sell or share your information to third parties.
Not reporting a typo? Please use our Contact Form